Technology: Biopharma, Biotechnology
Industry: Clinical Development, Preclinical Development
Headquarters: Huangpu, Shanghai, China
Founded Date: 2019-01-01
Employees Number: 251-500
Funding Status: IPO
Acquisitions Number: 2
Investors Number: 20
Total Funding: 342000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-11-29
Last Funding Type: Post-IPO Equity

Visit Website
media@transcenta.com
Register and Claim Ownership